Landscapes / Companies

Hangzhou Hanx Biopharmaceuticals, Ltd. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
 
Next date
Narazaciclib, Phase 1/2 trial completes
Drugs
2
in active trials
Trials
2 active
6 since 2021

Drugs2

DrugHow it worksPartnerStageNext dateDetails
Cyclin-dependent kinase inhibitor
Phase 1/2 31 Dec 2026Phase 1/2 trial completes
—
Phase 1/2 31 Dec 2027Phase 1/2 trial completes

About

SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Hangzhou Hanx Biopharmaceuticals, Ltd.

Following is part of Solo: you see every change to Hangzhou Hanx Biopharmaceuticals, Ltd. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in